| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 12/20/1991 | WO1991019786A1 Type-c rotavirus cultures and uses therefor | 
| 12/20/1991 | CA2076396A1 Type-c rotavirus cultures and uses therefor | 
| 12/19/1991 | WO1991019802A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris | 
| 12/19/1991 | WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use | 
| 12/19/1991 | CA2085580A1 Bacteriocin from a strain of lactococcus lactis subsp. cremoris | 
| 12/19/1991 | CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use | 
| 12/19/1991 | CA2044741A1 Hiv gp120 monoclonal antibodies | 
| 12/18/1991 | EP0461560A1 Recombinant human hepatocyte growth factor and method for production thereof | 
| 12/18/1991 | EP0461180A1 Development of a monoclonal antibody based detection system for listeria monocytogenes | 
| 12/18/1991 | EP0461177A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine | 
| 12/18/1991 | EP0461159A1 Il-2 analogs containing n-linked glycosylation sites | 
| 12/18/1991 | EP0455741A4 Method for detecting inhibitors of tat protein | 
| 12/18/1991 | EP0108128B1 (met-1,des-cys1,des-tyr2,des-cys3) human gamma interferon and a dna sequence encoding it | 
| 12/18/1991 | CN1057072A Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing same | 
| 12/17/1991 | US5073493 Monoclonal antibody nky13 | 
| 12/16/1991 | WO1991019805A1 A novel vector to produce biologically important peptides | 
| 12/16/1991 | WO1991019742A1 Crystalline interleukin-4 | 
| 12/16/1991 | CA2085377A1 Crystalline interleukin-4 | 
| 12/16/1991 | CA2084678A1 Vector to produce biologically important peptides | 
| 12/14/1991 | WO1991019811A1 Process for producing peptides | 
| 12/14/1991 | WO1991019745A1 Chimeric toxins with improved inter-domain geometry | 
| 12/14/1991 | WO1991019494A1 Compositions for treating hiv-type 1 infection | 
| 12/14/1991 | CA2085234A1 Compositions for treating hiv-type 1 infection | 
| 12/14/1991 | CA2083487A1 Chimeric toxins with improved inter-domain geometry | 
| 12/12/1991 | WO1991019739A1 Multivalent antigen-binding proteins | 
| 12/12/1991 | WO1991019009A1 The ciliary neurotrophic factor receptor | 
| 12/12/1991 | WO1991019008A1 A family of map2 protein kinases | 
| 12/12/1991 | WO1991019001A1 Immunodiagnostic assay for rheumatoid arthritis | 
| 12/12/1991 | WO1991018984A2 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi | 
| 12/12/1991 | WO1991018983A1 Recombinant protein which binds to a complex viral antigen of hiv-1 | 
| 12/12/1991 | WO1991018982A1 Type ii interleukin-1 receptors | 
| 12/12/1991 | WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide | 
| 12/12/1991 | WO1991018928A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use | 
| 12/12/1991 | WO1991018926A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE | 
| 12/12/1991 | WO1991018923A1 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them | 
| 12/12/1991 | WO1991018922A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) | 
| 12/12/1991 | WO1991018627A1 Swine pneumonia vaccine and method for the preparation thereof | 
| 12/12/1991 | WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays | 
| 12/12/1991 | WO1991015582A3 Purified rap gaps, rap gap sequences, and uses thereof | 
| 12/12/1991 | WO1991015512A3 Hiv envelope polypeptides | 
| 12/12/1991 | WO1991014778A3 BACILLUS THURINGIENSIS cryIIIC GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS | 
| 12/12/1991 | WO1991008291A3 Latency associated peptide and uses therefor | 
| 12/12/1991 | CA2082529A1 Immunodiagnostic assay for rheumatoid arthritis | 
| 12/12/1991 | CA2064829A1 Multivalent antigen-binding proteins | 
| 12/12/1991 | CA2064752A1 Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi | 
| 12/12/1991 | CA2044201A1 Inactive precursor forms of ribosome inactivating proteins, a process for making and a method of using | 
| 12/12/1991 | CA2042868A1 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates | 
| 12/11/1991 | EP0460910A2 Tumor cell growth inhibitor | 
| 12/11/1991 | EP0460882A2 Lipopeptide deacylase | 
| 12/11/1991 | EP0460846A1 Type II interleukin-1 receptors | 
| 12/11/1991 | EP0460753A2 New Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi | 
| 12/11/1991 | EP0460716A1 Yeast expression systems with vectors having GAPDH promoters, and synthesis of HBsAg | 
| 12/11/1991 | EP0460709A1 AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques | 
| 12/11/1991 | EP0460674A2 Recombinant DNA and process for the production of chimaeric antibodies | 
| 12/11/1991 | EP0460607A2 Novel monoclonal antibody to novel antigen associated with human tumors | 
| 12/11/1991 | EP0460217A1 cDNA OF ORSV GENE | 
| 12/11/1991 | EP0460190A1 Method for detecting malignant diseases. | 
| 12/11/1991 | EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems | 
| 12/11/1991 | EP0460177A1 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens | 
| 12/11/1991 | EP0460101A1 Immobilized cytokines | 
| 12/11/1991 | EP0460072A1 Human elastase inhibitor | 
| 12/11/1991 | EP0460052A1 Il-1 biological activity inhibitors | 
| 12/11/1991 | EP0460042A1 Vector for integration site independent gene expression in mammalian host cells | 
| 12/11/1991 | EP0460016A1 Metastasis-associated collagenolytic metalloproteinases. | 
| 12/11/1991 | EP0460014A1 Chymopapain fragmentation of monoclonal antibodies | 
| 12/11/1991 | EP0269728B1 Monoclonal antibodies to human lymphocyte ige receptors, hybridomas producing such antibodies, and kits for using such antibodies | 
| 12/11/1991 | EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used | 
| 12/10/1991 | US5071963 Interferon-induced human (2'-5') oligo a synthetase | 
| 12/10/1991 | US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution | 
| 12/10/1991 | US5071959 Novel lymphokine for suppressing platelet activation | 
| 12/10/1991 | US5071956 Glycoproteins for treating vision defects, arthritis, cardiovascular disorders, tumors and rheumatic dieseases | 
| 12/10/1991 | US5071773 Hormone receptor-related bioassays | 
| 12/10/1991 | US5071761 Dna sequence coding for human lymphoblastoid interferons | 
| 12/10/1991 | US5071759 Immunological cross-reactivity; immunoassay; colitis | 
| 12/10/1991 | US5071758 Veterinary medicine | 
| 12/10/1991 | US5071749 Glycopetide antibiotic pa-45052-b | 
| 12/10/1991 | US5071744 Fusing b-lymphocytes from immunized fouse with a transforming agent; cloning; elisa; enzyme inhibition | 
| 12/09/1991 | WO1991019011A1 Immunoassays for anti-hiv-1 antibodies | 
| 12/09/1991 | CA2082806A1 Immunoassays for anti-hiv-1 antibodies | 
| 12/09/1991 | CA2043516A1 Recombinant dna and process for the production of chimeric antibodies | 
| 12/08/1991 | WO1991018897A1 Therapeutic heterocyclic compounds | 
| 12/07/1991 | WO1991018920A1 Sm-d antigen peptides and their use, in particular, for the diagnosis of systemic lupus erythematosus | 
| 12/07/1991 | WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae | 
| 12/07/1991 | CA2064576A1 Sm-d antigen peptides and their use notably in the diagnostic of systemic lupus erythematosus | 
| 12/06/1991 | CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors | 
| 12/04/1991 | EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use | 
| 12/04/1991 | EP0459747A1 Precursor forms of porcine growth hormone releasing factor and related DNA compounds | 
| 12/04/1991 | EP0459630A2 Polypeptides | 
| 12/04/1991 | EP0459577A2 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors | 
| 12/04/1991 | EP0459564A2 Process for reduction of echinocandin type cyclohexapeptide compounds | 
| 12/04/1991 | EP0459450A2 Monoclonal antibody recognizing membrane phospholipase A2 and immunoassay of membrane phospholipase A2 | 
| 12/04/1991 | EP0459387A2 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit | 
| 12/04/1991 | EP0459372A2 Hybridoma and production of biologically active substance | 
| 12/04/1991 | EP0459190A2 Monoclonal anitbodies which bind mevalonate kinase | 
| 12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) | 
| 12/04/1991 | EP0458903A1 Soluble analogs of thrombomodulin | 
| 12/04/1991 | EP0182888B1 Method and reactant for the differential determination of isoenzymes of the alkaline phosphatase and monoclonal antibody therefore | 
| 12/04/1991 | CN1056713A Anti-oncostatin m monoclonal antibodies | 
| 12/04/1991 | CN1056712A Colone and/or express vectors, process of production and use thereof | 
| 12/03/1991 | US5070025 Process for the determination of a protein according to fluorescence polarization immunoassay principle |